[go: up one dir, main page]

AR021669A1 - Formulacion util para el mantenimiento y restitucion de la integridad intestinal - Google Patents

Formulacion util para el mantenimiento y restitucion de la integridad intestinal

Info

Publication number
AR021669A1
AR021669A1 ARP990106370A ARP990106370A AR021669A1 AR 021669 A1 AR021669 A1 AR 021669A1 AR P990106370 A ARP990106370 A AR P990106370A AR P990106370 A ARP990106370 A AR P990106370A AR 021669 A1 AR021669 A1 AR 021669A1
Authority
AR
Argentina
Prior art keywords
restitution
maintenance
useful formulation
intestinal integrity
intestinal
Prior art date
Application number
ARP990106370A
Other languages
English (en)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of AR021669A1 publication Critical patent/AR021669A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/04—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Una formulacion util para mantener y mejorar la restitucion de la integridad intestinal en un individuo que lo necesita, que comprende una cantidadefectiva de por lo menos un ácido graso poliinsaturado n-6 en combinacion con por lo menos un ácido graso poliinsaturado n-3.
ARP990106370A 1998-12-15 1999-12-14 Formulacion util para el mantenimiento y restitucion de la integridad intestinal AR021669A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11237498P 1998-12-15 1998-12-15

Publications (1)

Publication Number Publication Date
AR021669A1 true AR021669A1 (es) 2002-07-31

Family

ID=22343574

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990106370A AR021669A1 (es) 1998-12-15 1999-12-14 Formulacion util para el mantenimiento y restitucion de la integridad intestinal

Country Status (14)

Country Link
EP (1) EP1140063A1 (es)
JP (1) JP2002532420A (es)
KR (1) KR20020002361A (es)
CN (1) CN1330542A (es)
AR (1) AR021669A1 (es)
AU (1) AU3119600A (es)
BR (1) BR9916156A (es)
CA (1) CA2351469A1 (es)
EA (1) EA200100662A1 (es)
HU (1) HUP0104760A2 (es)
IL (1) IL143322A0 (es)
NO (1) NO20012947D0 (es)
PL (1) PL348810A1 (es)
WO (1) WO2000035443A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112509A2 (en) * 2003-06-23 2004-12-29 Nestec S.A. Nutritional formula for optimal gut barrier function
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
JP2007063219A (ja) * 2005-09-01 2007-03-15 Juntendo 新生児壊死性腸炎疾患予防剤
EP2658403B1 (en) 2010-12-29 2018-05-02 Abbott Laboratories Nutritional product for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child
MX2017003660A (es) * 2014-09-30 2017-06-26 Nestec Sa Composicion nutricional que se usa para promover la maduracion y/o reparacion del intestino y/o del higado.
WO2023245470A1 (zh) * 2022-06-22 2023-12-28 南方医科大学珠江医院 Mdp类似物在制备用于治疗炎症性肠病的药物中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670285A (en) * 1982-08-06 1987-06-02 The University Of Toronto Innovations Foundation Infant formula
DE3603000A1 (de) * 1986-01-31 1987-08-06 Milupa Ag Neue polyensaeure-reiche fettmischung und deren verwendung bei der herstellung von saeuglingsnahrungen
GB9224809D0 (en) * 1992-11-26 1993-01-13 Scotia Holdings Plc Schizophrenia
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
DE4417851C1 (de) * 1994-05-20 1995-10-05 Horst Heirler Diätetisches Lebensmittel mit mittelkettigen Fettsäuren und dessen Verwendung
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
US5993221A (en) * 1997-05-01 1999-11-30 Beth Israel Deaconess Medical Center, Inc. Dietary formulation comprising arachidonic acid and methods of use

Also Published As

Publication number Publication date
EP1140063A1 (en) 2001-10-10
WO2000035443A1 (en) 2000-06-22
JP2002532420A (ja) 2002-10-02
CA2351469A1 (en) 2000-06-22
CN1330542A (zh) 2002-01-09
EA200100662A1 (ru) 2001-12-24
NO20012947L (no) 2001-06-14
AU3119600A (en) 2000-07-03
PL348810A1 (en) 2002-06-17
WO2000035443A9 (en) 2000-12-07
NO20012947D0 (no) 2001-06-14
BR9916156A (pt) 2001-09-04
KR20020002361A (ko) 2002-01-09
IL143322A0 (en) 2002-04-21
HUP0104760A2 (hu) 2002-04-29

Similar Documents

Publication Publication Date Title
ES2157568T3 (es) Fibras compuestas, apositos para heridas que incorporan dichas fibras y procedimiento de fabricacion de las mismas.
MX9306499A (es) Composiciones farmaceuticas que contienen una anfetamina.
NO991635D0 (no) Farmas°ytisk preparat omfattende eikospentaensyre og/eller stearidonsyre
DE60105547D1 (de) Verwendung von exendinen und deren agonisten zur behandlung von hypertriglyceridämie
AR024894A1 (es) Un dispositivo para peinar las pestanas y cejas y dispositivo de acondicionamiento y de aplicacion asi como su aplicador
PT1105122E (pt) Composicoes farmaceuticas que contem inibidores de lipase
BR0313775A (pt) aparelho e métodos de serviços da rede
MY110470A (en) Formulations containing unsaturated fatty acids
NO20004617L (no) Tablett som disintegrerer hurtig i munnhulen
PT783314E (pt) Composicoes para o tratamento de irds e de ards, que contem pelo menos um glucocorticosteroide em combinacao com um agente tensioactivo pulmonar
BR9912710A (pt) Plantas, sementes e óleos com elavado teor totalde ácidos graxos monoinsaturados
AR021669A1 (es) Formulacion util para el mantenimiento y restitucion de la integridad intestinal
MX9203725A (es) Composiciones farmaceuticas que comprenden una calcitonina y un glicirrizinato como aumentador de absorcion.
CO5210918A1 (es) Metodo para reducir grasa en recubrimientos a base de grasa para productos de confiteria
AR006801A1 (es) Una composicion para el acondicionamiento de la piel que contiene melinamida , retinol y/o ester de retinilo, y un metodo cosmetico no terapeutico para el acondicionamiento de la piel que comprende la aplicacion de dicha composicion.
AR010957A1 (es) MONOFILAMENTO Y PROCEDIMIENTO PARA LA ELABORACIoN DE CERDAS Y LIMPIADORES INTERDENTALES, ASí COMO ARTíCULOS ELABORADOS CON CERDAS Y LIMPIADORES INTERDENTALES.
CO4600725A1 (es) Composiciones insecticidas sinergisticas
AR021754A1 (es) Una composicion de acondicionador opaco
DE60013435D1 (de) Aus saaten gewonnenes öl mit modifizierter fettsäurezusammensetzung
ES2109632T3 (es) Composicion de dentifrico anhidro.
UA48245C2 (uk) ЗАМІЩЕНІ 1,2,3,4-ТЕТРАГІДРО-2-ДИБЕНЗОФУРАНАМІНИ ТА 2-АМІНОЦИКЛОГЕПТА[B]БЕНЗОФУРАНИ, ФАРМАЦЕВТИЧНА ЛІКАРСЬКА ФОРМА ТА СПОСІБ ПІДВИЩЕННЯ АКТИВАЦІЇ 5-НТ<sub>1F</sub> РЕЦЕПТОРА У ССАВЦЯ
AR006082A1 (es) Formulaciones farmacéuticas de liberación prolongada, que contienen mizolastina
BR9713349A (pt) Método e dispositivo para adaptar uma estrutura de ponte para ajustar elementos de ancoragem em uma mandìbula de paciente.
ATE335461T1 (de) Hautpräparat
ES2154444T3 (es) Procedimiento para la preparacion de 2-h-heptafluoropropano.